Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first line treatment of metastatic colorectal cancer


VAROL U., OKTAY E., YILDIRIM M., SURMELI Z. G. , DİRİCAN A., MEYDAN N., ...More

MOLECULAR AND CLINICAL ONCOLOGY, vol.2, no.1, pp.166-170, 2014 (Refereed Journals of Other Institutions)

  • Publication Type: Article / Article
  • Volume: 2 Issue: 1
  • Publication Date: 2014
  • Title of Journal : MOLECULAR AND CLINICAL ONCOLOGY
  • Page Numbers: pp.166-170